TNF-α-Induced Secretion of C-C Chemokines Modulates C-C Chemokine Receptor 5 Expression on Peripheral Blood Lymphocytes
暂无分享,去创建一个
[1] D. Markovitz,et al. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. , 1999, Journal of immunology.
[2] C. Martínez-A,et al. Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex. , 1999, Journal of immunology.
[3] S. Worgall,et al. Expression and Use of Human Immunodeficiency Virus Type 1 Coreceptors by Human Alveolar Macrophages , 1999, Journal of Virology.
[4] Antonio Lanzavecchia,et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function , 1999, European journal of immunology.
[5] S. Hanauer,et al. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. , 1999, Inflammatory bowel diseases.
[6] J. Gómez-Reino,et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. , 1999, Arthritis and rheumatism.
[7] K. Uhlig,et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. , 1999, Arthritis and rheumatism.
[8] D. Weissman,et al. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Okumura,et al. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. , 1999, International immunology.
[10] M. Oppermann,et al. Differential Effects of CC Chemokines on CC Chemokine Receptor 5 (CCR5) Phosphorylation and Identification of Phosphorylation Sites on the CCR5 Carboxyl Terminus* , 1999, The Journal of Biological Chemistry.
[11] J. Berzofsky,et al. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. , 1999, Journal of immunology.
[12] M. Lenardo,et al. NF‐κB regulates Fas / APO‐1 / CD95‐ and TCR‐mediated apoptosis of T lymphocytes , 1999 .
[13] F. Sánchez‐Madrid,et al. Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis , 1999, The Journal of cell biology.
[14] E. M. Rogers,et al. Nuclear factor-kappa B p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. , 1999, Journal of immunology.
[15] Y. Goltsev,et al. Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.
[16] R. Siegel,et al. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.
[17] N. Landau,et al. Functional analysis of the proximal CCR5 promoter. , 1998, AIDS research and human retroviruses.
[18] B. Levine,et al. Naı̈ve and Memory CD4 T Cells Differ in Their Susceptibilities to Human Immunodeficiency Virus Type 1 Infection following CD28 Costimulation: Implications for Transmission and Pathogenesis , 1998, Journal of Virology.
[19] Ping Wang,et al. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization , 1998, Journal of cellular biochemistry.
[20] C. Vita,et al. Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells , 1998, The Journal of experimental medicine.
[21] L. Zheng,et al. Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. , 1998, Immunity.
[22] Christoph Schaniel,et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation , 1998, European journal of immunology.
[23] H. Marquart,et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. , 1998, The Journal of rheumatology.
[24] J. Westwick,et al. Chemokines and T lymphocytes: more than an attraction. , 1998, Immunity.
[25] D. Littman. Chemokine Receptors: Keys to AIDS Pathogenesis? , 1998, Cell.
[26] M. Mack,et al. Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.
[27] A. Sica,et al. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. , 1998, Journal of immunology.
[28] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[29] S. Akira,et al. A novel lipopolysaccharide inducible C‐C chemokine receptor related gene in murine macrophages , 1998, FEBS letters.
[30] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[31] F. Goebel,et al. Lack of protection from HIV infection by the mutant HIV coreceptor CCR5 in intravenously HIV infected hemophilia patients. , 1998, Immunobiology.
[32] Hassan Mohammad Naif,et al. CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.
[33] J. Schlessinger,et al. Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5 , 1997, The Journal of experimental medicine.
[34] D. Weissman,et al. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor , 1997, Nature.
[35] L. Zheng,et al. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. , 1997, Journal of immunology.
[36] B. Cullen,et al. Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor , 1997, The EMBO journal.
[37] Jean Salamero,et al. HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.
[38] Nancy Sullivan,et al. CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.
[39] C. Katlama,et al. HIV-1 infection in an individual homozygous for CCR5▵32 , 1997, The Lancet.
[40] C. Winkler,et al. HIV-1 infection in a man homozygous for CCR5▵32 , 1997, The Lancet.
[41] C. Katlama,et al. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group. , 1997, Lancet.
[42] A. Fauci,et al. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. , 1997, Journal of immunology.
[43] C. Mackay,et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Giacca,et al. C–C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells , 1997, The Journal of experimental medicine.
[45] A. Sica,et al. Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes , 1997, The Journal of experimental medicine.
[46] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[47] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[48] Steven M. Wolinsky,et al. The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.
[49] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[50] T. Schall,et al. RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells , 1996, The Journal of experimental medicine.
[51] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[52] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[53] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[54] J. Boss,et al. TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene. , 1996, Immunity.
[55] D. Taub,et al. β Chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production , 1996, Journal of leukocyte biology.
[56] George Kollias,et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.
[57] M. Lenardo,et al. Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.
[58] B. Premack,et al. Activation of dual T cell signaling pathways by the chemokine RANTES. , 1995, Science.
[59] P. Murphy,et al. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.
[60] J. Woody,et al. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis , 1994, The Lancet.
[61] M. Baum,et al. Endometrial cancer during tamoxifen treatment , 1994, The Lancet.
[62] R. Binns,et al. RANTES and chemokines in rheumatoid arthritis , 1994, The Lancet.
[63] A. Hajeer,et al. RANTES role in rheumatoid arthritis , 1994, The Lancet.
[64] K. Tracey,et al. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.
[65] P. Murphy. The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.
[66] M. Plumb,et al. C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene , 1993, Molecular and cellular biology.
[67] A. Fischer,et al. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56Ick in human CD4 T lymphocytes , 1993, European journal of immunology.
[68] P. Vassalli,et al. The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.
[69] L. Gooding,et al. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.
[70] A. Israël,et al. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. , 1989, Journal of immunology.
[71] T. Mosmann,et al. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies , 1987, The Journal of experimental medicine.
[72] B. Bonavida,et al. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor. , 1987, Journal of immunology.
[73] J. Vilček,et al. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. , 1987, Journal of immunology.
[74] R. Coffman,et al. Two types of mouse helper T-cell clone Implications for immune regulation. , 1987, Immunology today.
[75] S. Liang,et al. Mediation of mouse natural cytotoxic activity by tumour necrosis factor , 1986, Nature.
[76] H. Holtmann,et al. Tumor necrosis factor induction by Sendai virus. , 1986, Journal of immunology.